KMDA

Kamada Ltd.

Price

$7.06

return (12m)

-5.82%

p/e

20.48

p/bv

1.61

DIVIDEND YIELD

3.53%

KMDA price

Kamada

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KMDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.75%

3 months

-13.90%

1 year

-5.82%

2 years

25.88%

5 years

37.45%

10 years

0.00%

Fundamentals KMDA

Valuation

P/E

20.48

Sector -4.03

Industry -4.03

P/BV

1.61

Sector 2.05

Industry 2.05

P/Revenue (PSR)

2.30

Sector -4.26

Industry -4.26

EV/EBITDA

36.48

Sector -238.32

Industry -238.32

EV/EBIT

61.65

Sector -670.55

Industry -670.55

P/EBITDA

10.90

Sector -4.23

Industry -4.23

P/EBIT

18.05

Sector -4.29

Industry -4.29

P/Total Assets

1.09

Sector 1.45

Industry 1.45

P/Ativo Circ. Liq.

5.52

Sector -11.51

Industry -11.51

P/Cap.Giro

2.99

Sector -11.45

Industry -11.45

EPS

0.35

Sector -2.20

Industry -2.20

BVPS

4.40

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

41.16%

Sector 36.28%

Industry 36.28%

EBITDA Margin

20.84%

Sector -16,822.56%

Industry -16,822.56%

EBIT Margin

12.33%

Sector -4,238,732.42%

Industry -4,238,732.42%

Operating Margin

13.98%

Sector -38.78%

Industry -38.78%

Net Profit Margins

11.21%

Sector -39.92%

Industry -39.92%

Giro Ativos

0.12

Sector 0.03

Industry 0.03

Profitability

ROE

7.85%

Sector -65.93%

Industry -65.93%

ROA

5.32%

Sector -66.10%

Industry -66.10%

ROIC

7.88%

Sector -2,918.81%

Industry -2,918.81%

Dividends

Dividend yield

3.53%

Sector -

Industry -

Payout

72.29%

Sector -

Industry -

Debt

Current Ratio

3.33

Sector 2.91

Industry 2.91

Dívida Líquida/EBITDA

-7.76

Sector -13,526,126.12

Industry -13,526,126.12

Dívida Líquida/EBIT

-13.11

Sector -3.66

Industry -3.66

Dívida Líquida/Patrimônio

-0.28

Sector -1.10

Industry -1.10

Dívida Bruta/Patrimônio

0.00

Sector -0.10

Industry -0.10

Equity/Assets

0.68

Sector 0.42

Industry 0.42

Liabilities/Assets

0.32

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

11.88%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Kamada ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$7.06

Fair Value

$5.89

Upside Return potential.

-16.62%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals KMDA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
KMDA	20.48	1.61	7.85%	3.53%	$417.13 M	11.21%
JNJ	30.06	7.44	24.76%	1.99%	$632.34 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
ABBV	126.05	-69.30	-54.98%	2.60%	$458.19 B	5.79%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
AZN	25.14	5.51	21.93%	1.90%	$261.15 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
BMY	17.28	6.25	36.19%	4.05%	$125.69 B	15.01%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
REGN	15.66	2.20	14.08%	0.55%	$69.27 B	29.65%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
BIIB	21.68	1.59	7.36%	0.00%	$29.75 B	13.81%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KMDA Historical Dividends

current DY: 3.53%

5-year average DY: 2.90%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/20/2026	04/06/2026	0.24960000
Dividends	03/14/2025	04/07/2025	0.20000000

ABOUT Kamada

Kamada Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

36 years

Founded: 1990

2013

Time since IPO - 13 years

408

Employees

Kamada Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $417.13 million, with shareholders equity totaling $259.39 million.

The company employs approximately 408 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kamada Ltd. reported $181.68 million in revenue, generating net income of $20.37 million.

Key financial metrics include a P/E ratio of 20.48, a price-to-book (P/B) ratio of 1.61, and a trailing twelve-month dividend yield of 3.53%.

The company trades under the ticker KMDA.

Market cap

$417.13 million

Net worth

$259.39 million

$259,390,000.00

Assets

$383.02 million

$383,020,000.00

Total Shares Outstanding

59.00 million

59,000,000

Average Daily Trading Volume

$44.87 Thousand

$44,866.00

Sector

Health Care

Industry

Biotechnology

KMDA

KMDA revenue and profits

Financial Results KMDA

DRAG THE FRAME TO SEE MORE DATA

KMDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$840.90 18,75% (12M)

P/E

21.59

0.39%

ROE

-570.98%

P/BV

-123.30

CAH - Cardinal Health

$228.03 46,64% (12M)

P/E

34.58

0.89%

ROE

-58.20%

P/BV

-20.13

JNJ - Johnson & Johnson

$263.40 61,26% (12M)

P/E

30.06

1.99%

ROE

24.76%

P/BV

7.44

MRK - Merck & Co.

$131.07 59,86% (12M)

P/E

36.33

2.56%

ROE

19.45%

P/BV

7.07

AZN - AstraZeneca

$169.26 19,89% (12M)

P/E

25.14

1.90%

ROE

21.93%

P/BV

5.51

ABBV - AbbVie

$259.36 41,86% (12M)

P/E

126.05

2.60%

ROE

-54.98%

P/BV

-69.30

NVO - Novo Nordisk

$48.77 --25,90% (12M)

P/E

11.48

3.79%

ROE

60.40%

P/BV

6.93

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$840.90 18,75% (12 M)

P/L

21.59

0.39%

ROE

-570.98%

P/VP

-123.30

CAH - Cardinal Health

$228.03 46,64% (12 M)

P/L

34.58

0.89%

ROE

-58.20%

P/VP

-20.13

JNJ - Johnson & Johnson

$263.40 61,26% (12 M)

P/L

30.06

1.99%

ROE

24.76%

P/VP

7.44

MRK - Merck & Co.

$131.07 59,86% (12 M)

P/L

36.33

2.56%

ROE

19.45%

P/VP

7.07

AZN - AstraZeneca

$169.26 19,89% (12 M)

P/L

25.14

1.90%

ROE

21.93%

P/VP

5.51

ABBV - AbbVie

$259.36 41,86% (12 M)

P/L

126.05

2.60%

ROE

-54.98%

P/VP

-69.30

NVO - Novo Nordisk

$48.77 --25,90% (12 M)

P/L

11.48

3.79%

ROE

60.40%

P/VP

6.93

Frequently Asked Questions

What is the price of Kamada (KMDA) today?

A cotação de Kamada (KMDA) hoje está em US$ 7.06, com uma variação de -5.82% em relação ao último ano. A cotação de Kamada (KMDA) iniciou o ano negociando na casa dos US$ 7.06 e hoje está em US$ 7.06. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Kamada (KMDA) e dados de ações do Ibovespa e mercados internacionais.

Quando Kamada (KMDA) paga dividendos?

No último ano, Kamada (KMDA) distribuiu dividendos no mês de April, totalizando US$ 0.25. O Dividend Yield referente aos 12 últimos meses é de 3.53%.

Is Kamada (KMDA) a good investment?

Atualmente, Kamada (KMDA) está cotada a US$ 7.06, com um P/L de 20.48, representando um desvio de 526% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -5.82 em sua cotação e distribuiu US$ 0.25 em dividendos, resultando em um Dividend Yield de 3.53%. O retorno total do acionista foi de -5.82%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kamada (KMDA) stock?

Investir em ações de Kamada (KMDA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Kamada (KMDA) yield today?

A rentabilidade de Kamada (KMDA) foi de -2.75% no último mês, -5.82% no último ano e 37.45% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.25 em dividendos, um Dividend Yield de 3.53%.

Se você quisesse comprar 100 ações de Kamada (KMDA) hoje, o investimento total seria de US$ 706.00, com base na cotação atual de US$ 7.06.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 664.91
Em 5 anos: US$ 970.40
Em 10 anos: US$ 706.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KMDA

Kamada Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KMDA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

current DY: 3.53%

5-year average DY: 2.90%

type

Ex - Dividend Date

payment date

value

ABOUT Kamada

Kamada Ltd.

United States

36 years

2013

408

PROFIT X PRICE KMDA

Financial Results KMDA

KMDA cash flow

Asset, Revenue and Profit Growth - KMDA

KMDA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions